Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.63 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.63 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.63 |
| ▸ | ITGAL | P20701 | 1/20 | 0.63 |
| ▸ | CA4 | P22748 | 1/20 | 0.63 |
| ▸ | CA6 | P23280 | 1/20 | 0.63 |
| ▸ | AHR | P35869 | 1/20 | 0.63 |
| ▸ | ADK | P55263 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.44 |
| ▸ | WNT3A | P56704 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indole SCHEMBL29966814 | 1.00 | TRPA1 (0.63) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL27639366 | 0.98 | TRPA1 (0.61) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL29127707 | 0.89 | TRPA1 (0.63) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL7593945 | 0.87 | TRPA1 (0.61) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL7634666 | 0.87 | TRPA1 (0.65) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL29504142 | 0.87 | TRPA1 (0.65) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL7634660 | 0.87 | TRPA1 (0.65) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL4752595 | 0.87 | TRPA1 (0.65) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL27448469 | 0.87 | TRPA1 (0.65) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL28479409 | 0.86 | TRPA1 (0.77) | TRPA1CA1CA2ITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1023 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | UNIV IOWA RES FOUND (US) | 2026-02-26 | — | — | US | claimed |
| CN-118937534-A | Fecal biomarker for yin deficiency syndrome of Alzheimer disease and application thereof | 辽宁中医药大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118562664-A | Lactobacillus mucosae capable of relieving colorectal cancer related to ulcerative colitis and application thereof | 江南大学 | 2024-08-30 | — | — | CN | claimed |
| CN-118566487-A | Device for diagnosing gastric cancer and device for predicting prognosis of gastric cancer patient | 清华大学 | 2024-08-30 | — | — | CN | claimed |
| CN-118091146-A | Neurodegenerative disease marker based on blood metabolites and application thereof | 中国科学院深圳先进技术研究院 | 2024-05-28 | — | — | CN | claimed |
| CN-117915926-A | Serometabonomics associated with Chimeric Antigen Receptor (CAR) T cell therapy | 得克萨斯州大学系统董事会 | 2024-04-19 | — | — | CN | claimed |
| US-20240010693-A1 | PEPTIDES FROM HUMAN B-CASEIN THAT HAVE ANTI-BACTERIAL ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-01-11 | — | — | US | claimed |
| EP-4243853-A2 | PEPTIDES FROM HUMAN B-CASEIN THAT HAVE ANTI-BACTERIAL ACTIVITY | The Regents of the University of California (US) | 2023-09-20 | — | — | EP | claimed |
| WO-2023066132-A1 | STARCH-INDOLE ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 山东善维免疫科技有限公司 | 2023-04-27 | — | — | WO | claimed |
| CN-115175575-A | Engineered bacterial compositions and uses thereof | 赛里斯治疗公司 | 2022-10-11 | — | — | CN | claimed |
| CN-1239548-A | Method for detecting or determining viruses | TONEN CORP (JP) | 1999-12-22 | — | — | CN | claimed |
| CN-1230994-A | Deformylation of f-MET peptides in bacterial expression system | MONSANTO CO (US) | 1999-10-06 | — | — | CN | claimed |
| EP-0917580-A1 | DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS | MONSANTO COMPANY (US) | 1999-05-26 | — | — | EP | claimed |
| US-5834243-A | DEFORMYLATING RECOMBINANT PROTEIN IN A BACTERIAL HOST CELL | MONSANTO TECHNOLOGY LLC | 1998-11-10 | — | — | US | claimed |
| WO-1998003664-A1 | DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS | MONSANTO COMPANY (US) | 1998-01-29 | — | — | WO | claimed |
| US-5366876-A | PLASMID FOR THE EXPRESSION OF HORMONE IN ESCHERICHIA | LUCKY LTD. (KR) | 1994-11-22 | — | — | US | claimed |
| US-5270180-A | Method for the production of salmon growth hormone using a synthetic gene | LUCKY, LTD. (KR) | 1993-12-14 | — | — | US | claimed |
| EP-0215388-B1 | PLASMID VECTOR AND A METHOD FOR REGULATION OF GENE EXPRESSION USING THE SAME | AJINOMOTO CO., INC. (JP) | 1991-12-04 | — | — | EP | claimed |
| EP-0215388-A1 | Plasmid vector and a method for regulation of gene expression using the same | AJINOMOTO CO., INC. (JP) | 1987-03-25 | — | — | EP | claimed |
| EP-0180192-A1 | Novel plasmids | RESEARCH ASSOCIATION FOR UTILIZATION OF LIGHT OIL (JP) | 1986-05-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | KYNU, AADAT, TPH1 | TRPA1 1052/4885CA1 2837/4885CA2 2711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.